Additionally, 59.1%, 53.3% and 54.2% of patients taking 5 mg, 10 mg, or 15 mg tirzepatide respectively achieved a 1-stage or greater fibrosis improvement without worsening of MASH versus 32.8% of patients on placebo
KPV Explore research-grade KPV manufactured to rigorous quality standards for laboratory and preclinical research
Caffeic acid phenethyl ester protects kidney mitochondria against ischemia/reperfusion induced injury in an in vivo rat model
Products like Ozempic and Wegovy, which contain semaglutide, have faced significant shortages, leading to approximately 11.1% of patients switching between different GLP-1 therapies within their first year of treatment
Here is our simple, stress-free process: Choose Your Fuel Browse our GLP-1 friendly hampers, grab ready meals, top up your snacks, or select your targeted supplements